Anxiety and its Influence on Quality of Life and Physical Function in Chronic Heart Failure Phenotypes
Keywords:
heart failure, anxiety, ejection fractionAbstract
Anxiety is a prevalent comorbidity in patients with chronic heart failure (CHF) and has a considerable impact on prognosis, quality of life, and physical function. This study aims to evaluate the frequency and characteristics of anxiety in patients with CHF, stratified into three phenotypes based on left ventricular ejection fraction (LVEF): reduced ejection fraction (HFrEF), mildly reduced ejection fraction (HFmrEF), and preserved ejection fraction (HFpEF).
References
Glassman, A.H. & O'Connor, C.M. (2019). Depression and heart disease: A clinical review. Journal of the American College of Cardiology
Jiang, W., et al. (2018). Anxiety, depression, and mortality in patients with heart failure. American Heart Journal
Kirkwood, R.A., et al. (2020). The impact of depression on patients with heart failure: A systematic review. Journal of Clinical Psychiatry,
Moser, D.K., et al. (2020). Depression and anxiety in heart failure: Prevalence, impact on outcomes, and management strategies. Journal of Clinical Medicine,
Freedland, K. E., et al. (2020). Depression and heart failure: Pathophysiology and management. Journal of Cardiology, 76(3), 215–222.
Packer, M. (2021). Role of systemic inflammation in heart failure with reduced and preserved ejection fraction. European Journal of Heart Failure, 23(2), 324–334.
Beattie, J. M., et al. (2019). Depression in heart failure: Prevalence and implications for treatment. American Journal of Cardiology, 123(4), 622–630.
Rutledge, T., et al. (2016). Depression in chronic heart failure: Impact on prognosis and quality of life. Circulation: Heart Failure, 9(12), e003641.
Lam, C. S. P., et al. (2022). Heart failure with preserved ejection fraction: A systemic review of pathophysiology and clinical outcomes. Nature Reviews Cardiology, 19(3), 203–214.
Chung, M. L., et al. (2021). Interrelationships among depression, functional status, and quality of life in heart failure patients. Heart & Lung, 50(5), 666–673.
